array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(550)
}
["articles"]=>
array(4) {
[0]=>
array(7) {
["title_en"]=>
string(17) "Lecta - 03 - Link"
["snippet_en"]=>
string(311) "From left to right Wil-jan Schut (director VDL ETG Eindhoven), Bo-Inge Stensson (Vice President – Procurement Elekta), Marileen Hesse (Senior Strategic Buyer Elekta), Jeroen Boekema (director VDL Konings), Rob Honneff (Business Manager VDL ETG Eindhoven), Dennis van Opzeeland (director VDL ETG Suzhou),"
["url"]=>
string(122) "https://linkmagazine.nl/elekta-verkiest-vdl-groep-tot-leverancier-van-het-jaar-tijdens-mondiale-leveranciersdag/elekta-03/"
["image_url"]=>
NULL
["source"]=>
string(15) "linkmagazine.nl"
["publication_date"]=>
string(10) "2018-09-21"
["categories"]=>
array(2) {
[0]=>
string(12) "Staff hiring"
[1]=>
string(12) "Board Change"
}
}
[1]=>
array(7) {
["title_en"]=>
string(61) "Elekta appoints Niklas Savander as its next President and ..."
["snippet_en"]=>
string(249) "Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working"
["url"]=>
string(136) "https://www.elekta.com/pressreleases/4B4706F6762CB71F/elekta-appoints-niklas-savander-as-its-next-president-and-chief-executive-officer/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1701abce-f3ac-43cf-a263-ee82c56979d4"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2014-05-01"
["categories"]=>
array(4) {
[0]=>
string(12) "Staff hiring"
[1]=>
string(10) "Executives"
[2]=>
string(20) "Corporate Governance"
[3]=>
string(12) "Board Change"
}
}
[2]=>
array(7) {
["title_en"]=>
string(67) "Elekta appoints Niklas Savander as its next President and Chief ..."
["snippet_en"]=>
string(188) "25-10-2013 · Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas …"
["url"]=>
string(134) "https://ir.elekta.com/investors/press-releases/2013/elekta-appoints-niklas-savander-as-its-next-president-and-chief-executive-officer/"
["image_url"]=>
NULL
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2013-10-25"
["categories"]=>
array(4) {
[0]=>
string(12) "Staff hiring"
[1]=>
string(10) "Executives"
[2]=>
string(20) "Corporate Governance"
[3]=>
string(12) "Board Change"
}
}
[3]=>
array(7) {
["title_en"]=>
string(83) "Elekta Awarded the 2012 Queens Award for Enterprise in International Trade Category"
["snippet_en"]=>
string(247) "Crawley 2012-04-20 Henry Smith MP tours Crawley facility, home of the first digital linear accelerator, briefed on cancer treatment innovation and new jobs Elekta, a global medical technology company dedicated to oncology and neuroscience clinical"
["url"]=>
string(149) "https://www.elekta.com/press/75b5822d-1569-41d4-aba3-e5dd8cd6ad21/elekta-awarded-the-2012-queens-award-for-enterprise-in-international-trade-category"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9df21ebc-5e83-4f68-90a9-3aa7ceabaad1"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2012-04-20"
["categories"]=>
array(3) {
[0]=>
string(12) "Staff hiring"
[1]=>
string(5) "Award"
[2]=>
string(27) "Business Model & Innovation"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
550 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas Savander will succeed Tomas Puusepp, who will continue with Elekta as a working
25-10-2013 · Stockholm, October 25 – Elekta announced today that Niklas Savander has been appointed as its next President and Chief Executive Officer, effective May 1, 2014. Niklas …
Crawley 2012-04-20 Henry Smith MP tours Crawley facility, home of the first digital linear accelerator, briefed on cancer treatment innovation and new jobs Elekta, a global medical technology company dedicated to oncology and neuroscience clinical
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
